26 January, 2024
We warmly welcomed a 6-member Bhutan Food and Drug Authority team as they visited our ABHL plant for the GMP certificate renewal audit from January 24-26, 2024. We are excited to announce the audit's success, reaffirming our commitment to excellence. To mark this milestone, we captured memorable moments with the BFDA team during their visit and are grateful to the BFDA team for their meticulous evaluation and collaboration. We are delighted that collaboratively, we are paving the way for excellence in the pharmaceutical industry!
24 February, 2024
Transforming Bhutan’s Healthcare Azista Bhutan Healthcare Limited Leads the Charge Thimphu, Bhutan24 February, 2024
Team Blood Donation Drive28 December, 2024
A Plant Visit Recap - ABHL Hosts DHI Group's Menjong Sorig20th May 2026
Azista Bhutan Healthcare Limited (ABHL) had the privilege of welcoming its newly appointed Board Chairman, Dasho Mr. P. Dorji Gyeltshen, for a courtesy visit to the ABHL Motanga Formulation Facility on 20th May 2026, with Our CEO, Mr. PBC Obula Reddy.
During the visit, the Board Chairman toured the facility and interacted with the ABHL team to review current production capacity, operational progress, and future expansion plans. Meaningful discussions were held on third-country approvals, business strategies, and the continued support and facilitation extended by the Royal Government of Bhutan towards strengthening the healthcare and pharmaceutical sector.
The visit reflects ABHL’s growing vision of building manufacturing excellence with a global outlook and establishing a strong foundation for the future.
We sincerely thank the Board Chairman, Dasho Mr. P. Dorji Gyeltshen, for his valuable visit, guidance, and encouragement to the team.
Take a glimpse of the pictures capturing memorable moments from the visit and the inspiring interactions with the ABHL team.
To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.